Home
Synlogic

Synlogic Market Share Analysis for May 2026

Synlogic’s pipeline includes advancing drug candidates to treat phenylketonuria (PKU), homocystinuria (HCU), enteric hyperoxaluria, and gout.

Health > Biotechnology and Pharmaceuticals

Domainsynlogictx.com

Year Founded2013

Employees51 - 200

Annual Revenue$1M - $2M

Synlogic

Synlogic (including company regionals)

synlogictx.com

See more website traffic and engagement information

Synlogic Revenue up to May 2026 is 1M - 2M

revenue generated by Synlogic top domains

Synlogic top domains revenue over 3 years

Revenue for Synlogic top domains

synlogictx.com1M - 2M

See more with Sales Intelligence

Total visits to Synlogic's top domains

Understand Synlogic market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

synlogictx.com2.8K

See more with Sales Intelligence

Avg. visit duration in Synlogic's top domains

Analyze Synlogic engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

synlogictx.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Synlogic's top domains

See how Synlogic keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

synlogictx.com1.42

See more with Sales Intelligence

Synlogic top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Synlogic

These are the website technologies, by industry, used by Synlogic top domains

Widget (6)

Twemoji

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

Advertising (2)

DoubleClick

More Technologies

8

See all

News & Signals from Synlogic

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSynlogic Inc. hired James Flynn as Board amidst Director resignations on Jan 1st '26.Synlogic appoints James Flynn to Board amidst Director resignations.

NewsAoife Brennan leaves Synlogic Inc. as Chief Executive.Synlogic also announced that Chief Executive Aoife Brennan would step down as part of the workforce reduction.

NewsSynlogic Inc. launches SYNB1353.CAMBRIDGE, Mass. - Synlogic, Inc. (NASDAQ:SYBX), a clinical-stage biopharmaceutical company, has announced the publication of a study demonstrating the safety and mechanism of SYNB1353, a therapeutic candidate for classical homocystinuria (HCU), in preclinical models and a healthy volunteer study.